Synopsis
Synopsis
0
USDMF
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Apo Flurazepam
2. Apo-flurazepam
3. Dalmadorm
4. Dalmane
5. Dihydrochloride, Flurazepam
6. Dormodor
7. Flurazepam
8. Flurazepam Dihydrochloride
9. Flurazepam Hydrochloride
10. Flurazepam Mono Perchlorate
11. Flurazepam Mono-perchlorate
12. Hydrochloride, Flurazepam
13. Mono-perchlorate, Flurazepam
14. Monohydrochloride, Flurazepam
15. Staurodorm
1. 36105-20-1
2. Dalmate
3. 7c4jh842ij
4. Dalmadorm
5. Dalmane
6. Felison
7. Linzac
8. Natam
9. Insumin Dihydrochloride
10. 7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-3h-1,4-benzodiazepin-2-one;hydrochloride
11. 2h-1,4-benzodiazepin-2-one, 7-chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1,3-dihydro-, Monohydrochloride
12. 7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-1,3-dihydro-2h-benzo-1,4-diazepin-2-one Monohydrochloride
13. 7-chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1,3-dihydro-2h-benzo-1,4-diazepin-2-one Monohydrochloride
14. Id 480
15. Einecs 252-867-1
16. Unii-7c4jh842ij
17. Fluzepam
18. Dalmate (tn)
19. Fluorazepam Hydrochloride
20. Schembl29794
21. Chebi:31626
22. Flurazepam Hydrochloride (jp17)
23. Dtxsid40189686
24. Nsc78559
25. Flurazepam Monohydrochloride [mart.]
26. D01408
27. Flurazepam Monohydrochloride [ep Monograph]
28. Q27268050
29. Wln: T67 Gnv Jn Ihj Cg G2n2&2 Kr Bf &gh 2
30. 2h-1, 7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-1,3-dihydro-, Dihydrochloride
31. 2h-1, 7-chloro-1-[2-(diethylamino)ethyl]-5-(o-fluorophenyl)-1,3-dihydro-, Dihydrochloride
32. 2h-1, 7-chloro-1-[2-(diethylamino)ethyl]-5-(o-fluorophenyl)-,1,3-dihydro-, Dihydrochloride
33. 2h-1,4-benzodiazepin-2-one, 7-chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1,3-dihydro-, Hydrochloride (1:1)
34. 7-chloro-1-[2-(diethylamino)ethyl]-5-(o-fluorophenyl)-1,4-benzodiazepin-2-one Dihydrochloride
35. Flurazepam Monohydrochloride; 7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-1,3-dihydro-2h-benzo-1,4-diazepin-2-one Monohydrochloride; 2h-1,4-benzodiazepin-2-one, 7-chloro-1-[2-(diethylamino)ethyl]-5-(o-fluorophenyl)-,1,3-dihydro-, Dihydrochloride
| Molecular Weight | 424.3 g/mol |
|---|---|
| Molecular Formula | C21H24Cl2FN3O |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 6 |
| Exact Mass | 423.1280459 g/mol |
| Monoisotopic Mass | 423.1280459 g/mol |
| Topological Polar Surface Area | 35.9 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 540 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Flurazepam hydrochloride |
| Drug Label | Flurazepam hydrochloride is chemically 7-chloro-1-[2-(diethylamino)ethyl]-5-(o-fluoro-phenyl)-1,3dihydro-2H-1,4-benzodiazepin-2-one dihydrochloride. It is a pale yellow, crystalline compound, freely soluble in alcohol and very soluble in water. It ha... |
| Active Ingredient | Flurazepam hydrochloride |
| Dosage Form | Capsule |
| Route | Oral |
| Strength | 30mg; 15mg |
| Market Status | Prescription |
| Company | Mylan Pharms |
| 2 of 2 | |
|---|---|
| Drug Name | Flurazepam hydrochloride |
| Drug Label | Flurazepam hydrochloride is chemically 7-chloro-1-[2-(diethylamino)ethyl]-5-(o-fluoro-phenyl)-1,3dihydro-2H-1,4-benzodiazepin-2-one dihydrochloride. It is a pale yellow, crystalline compound, freely soluble in alcohol and very soluble in water. It ha... |
| Active Ingredient | Flurazepam hydrochloride |
| Dosage Form | Capsule |
| Route | Oral |
| Strength | 30mg; 15mg |
| Market Status | Prescription |
| Company | Mylan Pharms |
GABA Modulators
Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here. (See all compounds classified as GABA Modulators.)
Anti-Anxiety Agents
Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)
Hypnotics and Sedatives
Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?
